Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levosalbutamol (0.63mg) Respule
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Respule
Packaging Type
Pack
Packaging
4x5x2.5ml
Price
₹95/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Critsal 0.63 Respule is a respiratory solution containing Levosalbutamol (0.63mg) designed to manage bronchospasm in conditions like asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol, a short-acting beta-2 agonist (SABA), functions by relaxing the smooth muscles in the airways, facilitating better airflow and reducing respiratory distress. This medication is particularly effective for relieving acute asthma symptoms such as wheezing, shortness of breath, and chest tightness.
Administered via nebulization, Critsal 0.63 Respule ensures targeted delivery directly to the lungs, offering quick relief. The respule format is ideal for patients who have difficulty using inhalers, including children and elderly individuals. By providing rapid and effective bronchodilation, this medication supports improved breathing and overall respiratory health. It is an essential part of the therapeutic arsenal for individuals requiring immediate and efficient management of respiratory conditions.
May cause mild side effects such as tremors, headache, dizziness, palpitations, or throat irritation. Severe reactions are uncommon but should be reported to a healthcare provider.
Indicated for the treatment and prevention of bronchospasm associated with asthma and COPD.
Use only as prescribed by a healthcare professional. Do not exceed the recommended dosage, and consult your doctor if symptoms persist or worsen.
Store at a temperature below 25°C, in a cool and dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Budesonide (0.5mg) Respule
Composition : Sodium chloride 3% respules
Composition : Budesonide (0.5mg) + Formoterol (20mcg) Respule
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Glycopyrrolate (25mcg) Respule
Composition : Levosalbutamol 0.63 mg + Ipratropium 500 mcg respule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levosalbutamol 0.63mg Respules are used in nebulization therapy for asthma, COPD, bronchospasm, wheezing, and acute breathing difficulty. It is a strong respiratory and hospital-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong and continuous demand in hospitals, emergency departments, ICUs, and respiratory clinics. It is widely used in nebulizer treatments for acute asthma and COPD attacks, ensuring consistent institutional and pharmacy sales.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and nebulization formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from hospital procurement, emergency respiratory care demand, ICU usage, and steady repeat orders in chronic respiratory disease management when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this nebulization formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.